Home > Industry Projects > Oncology > Erbitux (Cetuximab) - Investigational Biological
In July 2002, ImClone Systems secured FDA approval for the production of Erbitux for use in clinical studies.
Copyright 2007SPG Media Limited a subsidiary of SPG Media Group PLC
